Literature DB >> 7683197

An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the delta F508 CFTR mutation.

K Kunzelmann1, E M Schwiebert, P L Zeitlin, W L Kuo, B A Stanton, D C Gruenert.   

Abstract

The development of transformed human airway epithelial cell lines has been important in advancing the understanding of the biochemical and genetic mechanisms underlying the cystic fibrosis (CF) defect. Since the most common mutation associated with CF is a phenylalanine deletion at position 508 (delta F508) in the CF transmembrane conductance regulator (CFTR) gene, a transformed airway epithelial cell line homozygous for this mutation will be important for determining the biologic significance of this mutation in the airways. We report the genotypic and phenotypic characterization of a delta F508 homozygote cell line derived from luminal epithelium in the trachea. The cells were transformed with a plasmid containing an origin of replication defective SV40 genome and have progressed through crisis. Immunocytochemical characterization of the cells shows that they express keratin, indicating epithelial cell origin, and that a calcium-dependent cell adhesion molecule, cellCAM 120/80, is present at plasma membrane junctions between cells. Electrophysiologically, the cells show no cAMP-dependent Cl transport. However, after treatment with the calcium ionophore, ionomycin, cells secrete Cl, albeit at a lower level than that observed in normal cells. Genetically, the cells express CFTR mRNA as determined by polymerase chain reaction amplification and CFTR protein as determined by Western hybridization analysis. Karyotypic analysis shows that 70% of the cells contain two copies of chromosome 7.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683197     DOI: 10.1165/ajrcmb/8.5.522

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  49 in total

1.  Intracellular compartmentalization of DNA fragments in cultured airway epithelial cells mediated by cationic lipids.

Authors:  A R Holmes; A F Dohrman; A R Ellison; K K Goncz; D C Gruenert
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Differential In Vitro and In Vivo Toxicities of Antimicrobial Peptide Prodrugs for Potential Use in Cystic Fibrosis.

Authors:  Éanna Forde; André Schütte; Emer Reeves; Catherine Greene; Hilary Humphreys; Marcus Mall; Deirdre Fitzgerald-Hughes; Marc Devocelle
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  Efficient delivery of RNA interference oligonucleotides to polarized airway epithelia in vitro.

Authors:  Shyam Ramachandran; Sateesh Krishnamurthy; Ashley M Jacobi; Christine Wohlford-Lenane; Mark A Behlke; Beverly L Davidson; Paul B McCray
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-26       Impact factor: 5.464

Review 4.  Impact of gene editing on the study of cystic fibrosis.

Authors:  Patrick T Harrison; David J Sanz; Jennifer A Hollywood
Journal:  Hum Genet       Date:  2016-06-21       Impact factor: 4.132

5.  Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside.

Authors:  Dušan Garić; Juan B De Sanctis; Gabriella Wojewodka; Daniel Houle; Shanon Cupri; Asmahan Abu-Arish; John W Hanrahan; Marian Hajduch; Elias Matouk; Danuta Radzioch
Journal:  J Mol Med (Berl)       Date:  2017-07-10       Impact factor: 4.599

6.  SYVN1, NEDD8, and FBXO2 Proteins Regulate ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitin-mediated Proteasomal Degradation.

Authors:  Shyam Ramachandran; Samantha R Osterhaus; Kalpaj R Parekh; Ashley M Jacobi; Mark A Behlke; Paul B McCray
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

7.  The tyrosine kinase BceF and the phosphotyrosine phosphatase BceD of Burkholderia contaminans are required for efficient invasion and epithelial disruption of a cystic fibrosis lung epithelial cell line.

Authors:  Ana S Ferreira; Inês N Silva; Fábio Fernandes; Ruth Pilkington; Máire Callaghan; Siobhán McClean; Leonilde M Moreira
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

8.  Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor).

Authors:  Elizabeth Matthes; Julie Goepp; Graeme W Carlile; Yishan Luo; Kurt Dejgaard; Arnaud Billet; Renaud Robert; David Y Thomas; John W Hanrahan
Journal:  Br J Pharmacol       Date:  2016-01-13       Impact factor: 8.739

9.  Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels.

Authors:  Beate Illek; Rosalie Maurisse; Logan Wahler; Karl Kunzelmann; Horst Fischer; Dieter C Gruenert
Journal:  Cell Physiol Biochem       Date:  2008-07-25

10.  The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease.

Authors:  David P Nichols; Assem G Ziady; Samuel L Shank; Jean F Eastman; Pamela B Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-21       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.